Three entities under China Merchants Group (CMG) have led a USD 80m Series B round for Porton Advanced Solutions, a local contract development and manufacturing organisation (CDMO) that focuses solely on gene and cell therapy services.
China Merchants Health Care Holdings, a dedicated healthcare investment platform under CMG, China Merchants Capital, and China Merchants Securities Investment were the lead investors. Other commitments...
Asian private equity has moved on from chasing momentum plays, with GPs increasingly pursuing opportunities where they have domain expertise and know they can add value, the AVCJ Private Equity & Venture Forum heard.
An emerging technology giant has imploded. Regulations are set to tighten. Investors hit pause but remain confident about the long-term outlook. Business as usual in crypto
Patrick Reid, a UK-based managing director for alternatives distribution management at Morgan Stanley, plots the future of themes around secondaries, longer holds, and hybrid approaches to PE
LionRock Capital is exiting Clarks to its majority partner, Li Ning-owned and Hong Kong-listed Viva China, having helped the struggling British shoe brand survive the pandemic